SEARCH

SEARCH BY CITATION

References

  • Ahn, Y.S. (2010) Triple play of H pylori in ITP. Blood, 115, 41554156.
  • Akpek, G., McAneny, D. & Weintraub, L. (1999) Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease. American Journal of Hematology, 61, 98102.
  • Balduini, C.L., Cattaneo, M., Fabris, F., Gresele, P., Iolascon, A., Pulcinelli, F.M. & Savoia, A. (2003) Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica, 88, 582592.
  • Barcellini, W., Montesano, R., Clerici, G., Zaninoni, A., Imperiali, F.G., Calori, R., Cortelezzi, A. & Zanella, A. (2002) In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. American Journal of Hematology, 71, 177183.
  • Bastion, Y., Coiffier, B., Dumontet, C., Espinouse, D. & Bryon, P.A. (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Annals of Oncology, 3, 171172.
  • Beardsley, D.S. & Ertem, M. (1998) Platelet autoantibodies in immune thrombocytopenic purpura. Transfusion Science, 19, 237244.
  • Berchtold, P., Muller, D., Beardsley, D., Fujisawa, K., Kaplan, C., Kekomaki, R., Lipp, E., Morell-Kopp, M.C., Kiefel, V., McMillan, R., von dem Borne, A.E. & Imbach, P. (1997) International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies. British Journal of Haematology, 96, 477483.
  • Borthakur, G., O’Brien, S., Wierda, W.G., Thomas, D.A., Cortes, J.E., Giles, F.J., Kantarjian, H.M., Lerner, S. & Keating, M.J. (2007) Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictors. British Journal of Haematology, 136, 800805.
  • Bowen, D.A., Call, T.G., Shanafelt, T.D., Kay, N.E., Schwager, S.M., Reinalda, M.S., Rabe, K.G., Slager, S.L. & Zent, C.S. (2010) Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone. Leukemia & Lymphoma, 51, 620627.
  • British Committee for Standards in Haematology (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adutls, children and in pregnancy. British Journal of Haematology, 120, 574596.
  • Bussel, J.B., Provan, D., Shamsi, T., Cheng, G., Psaila, B., Kovaleva, L., Salama, A., Jenkins, J.M., Roychowdhury, D., Mayer, B., Stone, N. & Arning, M. (2009) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet, 373, 641648.
  • Byrd, J.C., Hertler, A.A., Weiss, R.B., Freiman, J., Kweder, S.L. & Diehl, L.F. (1995) Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Annals of Oncology, 6, 300301.
  • Caligaris-Cappio, F. (1997) Relationship between autoimmunity and immunodeficiency in CLL. Hematology and Cell Therapy, 39, S13S16.
  • Chemnitz, J., Draube, A., Diehl, V. & Wolf, J. (2002) Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab. American Journal of Hematology, 69, 232233.
  • Chiorazzi, N., Rai, K.R. & Ferrarini, M. (2005) Chronic lymphocytic leukemia. New England Journal of Medicine, 352, 804815.
  • Dameshek, W. (1967) Chronic lymphocytic leukemia – an accumulative disease of immunolgically incompetent lymphocytes. Blood, 29 (Suppl.), 566584.
  • D’Arena, G. & Cascavilla, N. (2007) Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leukemia & Lymphoma, 48, 10721080.
  • D’Arena, G. & Cascavilla, N. (2011) Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia. Leukemia & Lymphoma, 52, 701704.
  • D’Arena, G., Capalbo, S., Laurenti, L., Del Poeta, G., Nunziata, G., Deaglio, S., Spinosa, G., Tarnani, M., Di Padua, L., Califano, C., Ferrara, F. & Cascavilla, N. (2010) Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients. European Journal of Haematology, 85, 502507.
  • Dearden, C. (2008) Disease-specific complications of chronic lymphocytic leukemia. Hematology, 450456.
  • Dearden, C., Wade, R., Else, M., Richards, S., Milligan, D., Hamblin, T. & Catovsky, D. (2008) The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood, 111, 18201826.
  • Dungarwalla, M., Marsh, J.C.W., Tooze, J.A., Lucas, G., Ouwehand, W., Pettengell, R., Dearden, C.E., Gordon Smith, E.C. & Elebute, M.O. (2007) Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Annals of Hematology, 86, 191197.
  • Dunleavy, K., Tay, K. & Wilson, W.H. (2010) Rituximab-associated neutropenia. Seminars in Hematology, 47, 180186.
  • Evans, R.S., Takahashi, K., Duane, R.T., Payne, R. & Liu, C. (1951) Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. Archives of Internal Medicine, 87, 4865.
  • Galton, D.A. (1966) The pathogenesis of chronic lymphocytic leukemia. Canadian Medical Association Journal, 94, 10051010.
  • Garratty, G. & Petz, L.D. (2007) Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy. British Journal of Haematology, 139, 622623.
  • Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology, 141, 149169.
  • Gentile, M., Lucia, E., Iorio, C., Vigna, E., Mazzone, C., Morelli, R., Bisconte, M.G., Gentile, C. & Morabito, F. (2008) Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient. Cancer Chemotherapy and Pharmacology, 62, 741743.
  • George, J.N. (2010) Management of immune thrombocytopenia – something old, something new. New England Journal of Medicine, 363, 19591961.
  • Ghazal, H. (2002) Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood, 99, 10921094.
  • Ghia, P., Scielzo, C., Frenquelli, M., Muzio, M. & Caligaris-Cappio, F. (2007) From normal to clonal B cells: chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity. Autoimmunity Reviews, 7, 127131.
  • Gribben, J.G. (2010) How I treat CLL up front. Blood, 115, 187197.
  • Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. & Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111, 54465456.
  • Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A.M., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G., von Grunhagen, U., Bergmann, M., Catalano, J., Zinzani, P.L., Caligaris-Cappio, F., Seymour, J.F., Berrebi, A., Jager, U., Cazin, B., Trneny, M., Westermann, A., Wendtner, C.M., Eichhorst, B.F., Staib, P., Buhler, A., Winkler, D., Zenz, T., Bottcher, S., Ritgen, M., Mendila, M., Kneba, M., Dohner, H. & Stilgenbauer, S. (2010) Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet, 376, 11641174.
  • Hamblin, T.J., Oscier, D.G. & Young, B.J. (1986) Autoimmunity in chronic lymphocytic leukaemia. Journal of Clinical Pathology, 39, 713716.
  • Hill, J., Walsh, R.M., McHam, S., Brody, F. & Kalaycio, M. (2004) Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature. American Journal of Hematology, 75, 134138.
  • Hodgson, K., Ferrer, G., Montserrat, E. & Moreno, C. (2011) Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica, doi: 10.3324/haematol 2010.036152 [Epub ahead of print]
  • Karlsson, C., Hansson, L., Celsing, F. & Lundin, J. (2007) Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia, 21, 511514.
  • Kaufman, M., Limaye, S.A., Driscoll, N., Johnson, C., Caramanica, A., Lebowicz, Y., Patel, D., Kohn, N. & Rai, K. (2009) A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia. Leukemia & Lymphoma, 50, 892899.
  • Kipps, T.J. & Carson, D.A. (1993) Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood, 81, 24752487.
  • Koehrer, S., Keating, M.J. & Wierda, W.G. (2010) Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP. Leukemia, 24, 10961098.
  • Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovick, F.T., de Wolf, J.T., Bourgeois, E., Guthrie, Jr, T.H., Newland, A., Wasser, J.S., Hamburg, S.I., Grande, C., Lefrere, F., Lichtin, A.E., Tarantino, M.D., Terebelo, H.R., Viallard, J.F., Cuevas, F.J., Go, R.S., Henry, D.H., Redner, R.L., Rice, L., Schipperus, M.R., Guo, D.M. & Nichol, J.L. (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet, 371, 395403.
  • Kuter, D.J., Mufti, G.J., Bain, B.J., Hasserjian, R.P., Davis, W. & Rutstein, M. (2009) Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood, 114, 37483756.
  • Kuter, D.J., Rummel, M., Boccia, R., Macik, B.G., Pabinger, I., Selleslag, D., Rodeghiero, F., Chong, B.H., Wang, X. & Berger, D.P. (2010) Romiplostim or standard of care in patients with immune thrombocytopenia. New England Journal of Medicine, 363, 18891899.
  • Kyasa, M.J., Parrish, R.S., Schichman, S.A. & Zent, C.S. (2003) Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Hematology, 74, 18.
  • Landgren, O., Engels, E.A., Caporaso, N.E., Gridley, G., Mellemkjaer, L., Hemminki, K., Linet, M.S. & Goldin, L.R. (2006) Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood, 108, 292296.
  • Landgren, O., Gridley, G., Check, D., Caporaso, N.E. & Morris Brown, L. (2007) Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. British Journal of Haematology, 139, 791798.
  • Laurenti, L., Tarnani, M., Efremov, D.G., Chiusolo, P., De Padua, L., Sica, S. & Leone, G. (2007) Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia. Leukemia, 21, 18191821.
  • Lechner, K. & Jager, U. (2010) How I treat autoimmune hemolytic anemias in adults. Blood, 116, 18311838.
  • Lewis, F.B., Schwartz, R.S. & Dameshek, W. (1966) X-radiation and alkylating agents as possible “trigger” mechanisms in the autoimmune complications of malignant lymphophroliferative disease. Clinical and Experimental Immunology, 1, 311.
  • Marchand, A., Galen, R.S. & van Lente, F. (1980) The predictive value of serum haptoglobin in haemolytic disease. Journal of the American Medical Association, 243, 19091911.
  • Mauro, F.R., Foa, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F. & Girelli, G. (2000) Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood, 95, 27862792.
  • Mazzucconi, M.G., Fazi, P., Bernasconi, S., De Rossi, G., Leone, G., Gugliotta, L., Vianelli, N., Avvisati, G., Rodeghiero, F., Amendola, A., Baronci, C., Carbone, C., Quattrin, S., Fioritoni, G., D’Alfonso, G. & Mandelli, F. (2007) Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood, 109, 14011407.
  • Moreno, C., Hodgson, K., Ferrer, G., Elena, M., Filella, X., Pereira, A., Baumann, T. & Montserrat, E. (2010) Autoimmune cytopenias in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood, 116, 47714776.
  • Myint, H., Copplestone, J.A., Orchard, J., Craig, V., Curtis, D., Prentice, A.G., Hamon, M.D., Oscier, D.G. & Hamblin, T.J. (1995) Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 91, 341344.
  • Narra, K., Borghaei, H., Al-Saleem, T., Höglund, M. & Smith, M.R. (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research, 30, 109114.
  • Owen, J., de Gruchy, G.C. & Smith, H. (1960) Serum haptoglobins in haemolytic states. Journal of Clinical Pathology, 13, 478482.
  • Pamuk, G.E., Turgut, B., Demir, M., Tezcan, F. & Vural, O. (2006) The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia. American Journal of Hematology, 81, 631633.
  • Petz, L. (1996) Blood Transfusion in the acquired hemolytic anemias. In: Clinical practice of Transfusion Medicine (ed. by L.Petz, S.N.Swisher, S.Kleinman, R.K.Spence & R.G.Strauss), pp. 469499. Churchill Livingstone, New York.
  • Poon, M.C. (2007) The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders. Transfusion Medicine Reviews, 21, 223236.
  • Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168186.
  • Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219234.
  • Riches, J.C., Ramsay, A.G. & Gribben, J.G. (2010) T-cell function in chronic lymphocytic leukaemia. Seminars in Cancer Biology, 20, 431438.
  • Rossignol, J., Michallet, A.S., Oberic, L., Picard, M., Garon, A., Willekens, C., Dulery, R., Leleu, X., Cazin, B. & Ysebaert, L. (2011) Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia. Leukemia, 25, 473478.
  • Royer, B., Vaida, I., Etienne, A., Garidi, R., Damaj, G. & Marolleau, J.P. (2007) Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab. Leukemia, 21, 18411842.
  • Sakurai, S., Shiojima, I., Tanigawa, T. & Nakahara, K. (1997) Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia. British Journal of Haematology, 99, 817823.
  • Sinisalo, M., Sankelo, M. & Itälä-Remes, M. (2011) Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia. Leukemia and Lymphoma, 52, 724725.
  • Söderberg, K.C., Jonsson, F., Winqvist, O., Hagmar, L. & Feychting, M. (2006) Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. European Journal of Cancer, 42, 30283033.
  • Swerdlow, S. & International Agency for Research on Cancer & World Health Organisation (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, France.
  • Tadmor, T. & Polliack, A. (2011) Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?. Leukemia and Lymphoma, 52, 558559.
  • Tosti, S., Caruso, R., D’Adamo, F., Picardi, A., Ali Ege, M., Girelli, G., Mauro, F.R., Maurillo, L. & Amadori, S. (1992) Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Annals of Hematology, 65, 238239.
  • Treleaven, J., Gennery, A., Marsh, J., Norfolk, D., Page, L., Parker, A., Saran, F., Thurston, J. & Webb, D. (2011) Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. British Journal of Haematology, 152, 3551.
  • Viny, A.D., Lichtin, A., Pohlman, B., Loughran, T. & Maciejewski, J. (2008) Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leukemia & Lymphoma, 49, 932938.
  • Visco, C., Giaretta, I., Ruggeri, M., Madeo, D., Tosetto, A. & Rodeghiero, F. (2007) Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia. Leukemia, 21, 10921093.
  • Visco, C., Ruggeri, M., Laura Evangelista, M., Stasi, R., Zanotti, R., Giaretta, I., Ambrosetti, A., Madeo, D., Pizzolo, G. & Rodeghiero, F. (2008) Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood, 111, 11101116.
  • Voog, E., Morschhauser, F. & Solal-Celigny, P. (2003) Neutropenia in patients treated with rituximab. New England Journal of Medicine, 348, 26912694.
  • Walker, R.H. (1990) American Association of Blood Banks Technical Manual. AABB, Arlington, VA.
  • Wolach, O., Bairey, O. & Lahav, M. (2010) Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine, 89, 308318.
  • Zent, C.S. & Kay, N.E. (2010) Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL). Best Practice & Research Clinical Haematology, 23, 4759.
  • Zent, C.S. & Shanafelt, T. (2009) Management of autoimmune cytopenia complicating chronic lymphocytic leukemia. Leukemia & Lymphoma, 50, 863864.
  • Zent, C.S., Ding, W., Schwager, S.M., Reinalda, M.S., Hoyer, J.D., Jelinek, D.F., Tschumper, R.C., Bowen, D.A., Call, T.G., Shanafelt, T.D., Kay, N.E. & Slager, S.L. (2008) The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology, 141, 615621.
  • Zent, C.S., Ding, W., Reinalda, M.S., Schwager, S.M., Hoyer, J.D., Bowen, D.A., Jelinek, D.F., Tschumper, R.C., Call, T.G., Shanafelt, T.D., Kay, N.E. & Slager, S.L. (2009) Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leukemia & Lymphoma, 50, 12611268.
  • Zenz, T., Mertens, D., Küppers, R., Döhner, H. & Stilgenbauer, S. (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nature Reviews. Cancer, 10, 3750.